Search results for:
alglucosidase alfa
alglucosidase alfa
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Lumizyme |
POWDER FOR INJECTION, INTRAVENOUS |
50 mg |
|
|
|
|
| Myozyme |
POWDER FOR INJECTION, INTRAVENOUS |
50 mg |
|
|
|
|
Last updated: Dec. 28, 2017
Both classified as restricted to outpatient, if case arises notify pharmacy administration for approval, each case will be evaluated on an individual basis, referral to a treatment center would be considered.
Lumizyme approved for a specific patient to receive at Outpatient Medical on a longterm basis.
Reviewed: June 27, 2006 (Myozyme), September 29, 2010 and September 25, 2013 (Lumizyme)